Mar 31, 2021 8:30 am EDT VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
Mar 30, 2021 8:30 am EDT VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
Mar 22, 2021 4:10 pm EDT VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
Mar 16, 2021 8:30 am EDT VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
Feb 12, 2021 9:25 am EST VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
Feb 10, 2021 9:18 am EST VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
Feb 9, 2021 4:01 pm EST VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
